Atrial dysfunction has been widely considered a marker or consequence of other cardiac
conditions rather than the cause itself. Here, we propose the term atrial failure as a clinically …

The last decade has witnessed remarkable advances in pharmacological and
nonpharmacological strategies for stroke prevention in patients with atrial fibrillation …

Aims The concept of “atrial cardiomyopathy”(AtCM) had been percolating through the
literature since its first mention in 1972. Since then, publications using the term were …

Background: Atrial myopathy—characterized by changes in left atrial function and size—may
precede and promote atrial fibrillation (AF) and cardiac thromboembolism. In people without …

Importance Atrial myopathy—characterized by alterations in left atrial (LA) function and size—
is associated with ischemic stroke, independent of atrial fibrillation (AF) …

Cardioaortic embolism to the brain accounts for approximately 15–30% of ischaemic strokes
and is often referred to as 'cardioembolic stroke'. One-quarter of patients have more than …

Clinically recognized atrial fibrillation (AF) is associated with higher risk of complications,
including ischemic stroke, cognitive decline, heart failure, myocardial infarction, and death. It …

Background: Atrial fibrillation (AF), mitral regurgitation (MR), and left ventricular (LV) ejection
fraction have a complex interplay. We evaluated the role of AF in patients with heart failure …

Atrial cardiomyopathy refers to structural and electrical remodelling of the atria, which can
lead to impaired mechanical function. While historical studies have implicated atrial …

Aims Left atrial (LA) volume and function impose significant impact on cardiovascular
pathogenesis if compromised. We aimed at investigating the genetic architecture of LA …